SXTC — China SXT Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for China SXT Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	15.5	17.4	12.1	18.1	28.2
Net Total Accounts Receivable
Net Total Receivables	5.53	1.34	1.35	1.9	3.23
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	22.5	19.5	14.2	21.3	34.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.59	1.27	0.565	0.355	0.239
Net Intangible Assets
Other Long Term Assets
Total Assets	33.5	29.6	23.1	21.7	34.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17.1	14.5	8.9	6.01	4.35
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.1	14.9	9.2	6.22	5.05
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	16.4	14.7	13.9	15.4	29.7
Total Liabilities & Shareholders' Equity	33.5	29.6	23.1	21.7	34.8
Total Common Shares Outstanding